Subscribe
william_potter
william_potter / iStockphoto.com
7 January 2019Americas

Eli Lilly to purchase Loxo Oncology for $8bn

American pharmaceutical firm Eli Lilly and Company has announced a deal to acquire Loxo Oncology in a $8 billion deal.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Eli Lilly to acquire cancer drug developer
15 May 2018   Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week.
Americas
Bayer collaborates with Loxo Oncology on cancer medicine
16 November 2017   Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025
Americas
Bankruptcy judge approves $305m sale of genetics testing company
1 July 2025
Americas
A step too far? Why Stewart’s approach is dividing opinion
24 June 2025
Europe
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
19 June 2025
Europe
UPC confirms permanent injunction against Curio in 10x tech dispute
17 June 2025
Americas
LSPN: In-house ‘chess game’ is the same, but the rules have changed
9 May 2025

More on this story

Americas
Eli Lilly to acquire cancer drug developer
15 May 2018   Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week.
Americas
Bayer collaborates with Loxo Oncology on cancer medicine
16 November 2017   Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion.

More on this story

Americas
Eli Lilly to acquire cancer drug developer
15 May 2018   Eli Lilly has revealed plans to acquire Montreal-based AurKa Pharma, in what is the company’s second acquisition in less than one week.
Americas
Bayer collaborates with Loxo Oncology on cancer medicine
16 November 2017   Bayer has entered into a global collaboration with biopharmaceutical company Loxo Oncology, in a deal that could be worth more than $1 billion.

More features

Startup challenges rival over brain monitoring tech at ITC
UKIPO rejects Boehringer’s SPC for horse inhaler
WilmerHale gains partner with ‘deep expertise’
Bayer, Orion take on Indian generic over $117bn drug
‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court